Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

832

[Sensitivity of AML Cells with FLT3- to PKC412 In Vitro].

Yin-Ying Wang1, Cong-Yan Liu1, Wei Zhang1

  • 1Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|October 27, 2017
PubMed
Summary

PKC412 (midostaurin) shows clinical value in treating acute myeloid leukemia (AML) patients without FLT3 mutations. Leukemia cell sensitivity to PKC412 may predict treatment effectiveness, independent of other factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation.

Journal of ethnopharmacology·2024
Same author

Application of Extracorporeal Membrane Oxygenation in Patients With Severe Acute Respiratory Distress Syndrome Caused by <i>Pneumocystis jirovecii</i> Pneumonia Following Kidney Transplantation: A Case Series.

Frontiers in physiology·2022
Same author

[Development of preparation process of icaritin-coix seed oil microemulsion based on quality by design concept].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2020
Same author

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.

Nature genetics·2017
Same author

Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.

BMC infectious diseases·2017
Same author

MD simulation study of the diffusion and local structure of n-alkanes in liquid and supercritical methanol at infinite dilution.

Journal of molecular modeling·2017

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • FLT3 mutations are common in AML and impact prognosis.
  • Targeted therapies are crucial for improving AML treatment outcomes.

Purpose of the Study:

  • To evaluate the clinical utility of PKC412 (midostaurin) in AML patients lacking FLT3 mutations.
  • To assess the correlation between in vitro sensitivity to PKC412 and clinical outcomes.

Main Methods:

  • Collected bone marrow or peripheral blood from 21 newly diagnosed FLT3-negative AML patients.
  • Isolated mononuclear cells and performed ATP-bioluminescence-tumor chemosensitivity assay (ATP-TCA) to determine sensitivity to PKC412 at eight concentrations.

More Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

982
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

832
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

982
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K
  • Analyzed the relationship between in vitro sensitivity, risk stratification, and therapeutic efficacy.

    • Main Results:

    • Leukemia cells from 42.9% of patients showed in vitro sensitivity to PKC412 at concentrations between 1-5 µmol/L.
    • No significant correlation was found between in vitro PKC412 sensitivity and risk stratification or clinical efficacy.
    • Patients in low- and intermediate-risk groups had better survival than those in the high-risk group (P=0.015).

    Conclusions:

    • PKC412 demonstrates potential as an effective treatment for FLT3-negative AML.
    • In vitro leukemia cell sensitivity to PKC412 may serve as an independent prognostic marker for clinical efficacy.